LEADER 01260nam  2200349 a 450 
001 9910698896103321
005 20090505113038.0
035   $a(CKB)5470000002396900
035   $a(OCoLC)320132596
035   $a(EXLCZ)995470000002396900
100   $a20090504d2009      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $elabel comprehension studies for nonprescription drug products : draft guidance
210  1$a[Beltsville, Md.] :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2009]
215   $a10 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on May 4, 2009).
300   $a"April 2009."
320   $aIncludes bibliographical references.
517   $aGuidance for industry 
606   $aDrugs, Nonprescription$xLabeling$zUnited States
615  0$aDrugs, Nonprescription$xLabeling
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698896103321
996   $aGuidance for industry$93434577
997   $aUNINA